| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |